Patent details

EP2152879 Title: RNA ANTAGONIST COMPOUNDS FOR THE MODULATION OF BETA-CATENIN

Basic Information

Publication number:
EP2152879
PCT Application Number:
PCT/EP/2008/055365
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP087499430
PCT Publication Number:
WO/2008/132234
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
RNA ANTAGONIST COMPOUNDS FOR THE MODULATION OF BETA-CATENIN
French Title of Invention:
COMPOSÉS ANTAGONISTES DE L'ARN POUR LA MODULATION DE LA BÉTA CATÉNINE
German Title of Invention:
RNA-ANTAGONISTENVERBINDUNGEN ZUR MODULATION VON BETA-CATENIN
SPC Number:

Dates

Filing date:
30/04/2008
Grant date:
14/11/2012
EP Publication Date:
14/11/2012
PCT Publication Date:
06/11/2008
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
17/02/2010
EP B1 Publication Date:
14/11/2012
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
30/04/2013
Expiration date:
30/04/2028
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
23/01/2013
 
 

Name:
Santaris Pharma A/S
Address:
Fremtidsvej 3, 2970 Hørsholm, Denmark (DK)

Inventor

Name:
WORM Jesper
Address:
Denmark (DK)

Priority

1

Priority Number:
23244
Priority Date:
25/02/1993
Priority Country:
United States (US)

2

Priority Number:
915371 P
Priority Date:
01/05/2007
Priority Country:
United States (US)

Classification

Main IPC Class:
C12N 15/113;
Filing date Document type Number of pages